Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

BACKGROUND: While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users. METHODS: We cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Shover, Carolyn M., Yan, Peter, Jackson, Nicholas J., Buhr, Russell G., Fulcher, Jennifer A., Tashkin, Donald P., Barjaktarevic, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356466/
https://www.ncbi.nlm.nih.gov/pubmed/35932069
http://dx.doi.org/10.1186/s42238-022-00152-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356466/
https://www.ncbi.nlm.nih.gov/pubmed/35932069
http://dx.doi.org/10.1186/s42238-022-00152-x

Ejemplares similares